A Randomised, Double-blind, Placebo-controlled Trial Assessing the Efficacy of SLITone in House Dust Mite Allergic Patients.
Phase of Trial: Phase II/III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
- Indications Allergic asthma; Rhinoconjunctivitis
- Focus Therapeutic Use
- 13 Feb 2010 New trial record